
MRI
Latest News


MRI Data in Phase 3 Study Shows Potential Impact of IL-23 Inhibitor for Treating Perianal Fistulizing Crohn’s Disease

Prostate MRI Study Shows Prognostic Value of PRECISE Scoring System for Active Surveillance of PCa
Latest Videos

Shorts






More News

Catch up on the top AI-related news and research in radiology over the past month.

In recent interviews, Andrew Del Gaizo, MD, Nicholas Galante, MD and David Larson, MD, MBA, shared their thoughts on the rapidly increasing imaging volume in radiology, key ramifications and possible solutions.


Catch up on a variety of new FDA clearances in radiology from the past week.

In a time-independent test set from a new retrospective study, gadoxetic-acid enhanced MRI provided nearly 38 percent higher sensitivity for detecting sub-centimeter hepatocellular carcinoma recurrence (HCC) in contrast to extracellular contrast agent-enhanced MRI.

For patients with cardiac dysfunction related to neoadjuvant chemotherapy for invasive breast cancer, new MRI research shows increased risks for concurrent decreases in total brain volume and white matter volume.

There was no statistically significant difference in sensitivity rates for lesion detection between breast MRI scans with minimum or mild background parenchymal enhancement (BPE) and those with moderate or marked BPE, according to a newly published study involving over 300 women.

A combination of time-dependent diffusion MRI-derived parameters and quantitative macromolecular proton fraction (MPF) demonstrated a 96 percent AUC for differentiating high-grade and low-grade cervical cancer, according to newly published research.

Catch up on the top radiology content of the past week.

Pre-op MRI detection of seminal vesicle invasion was associated with a greater than five times higher likelihood of metastatic failure for patients undergoing radical prostatectomy, according to a newly published meta-analysis.

Over a 10-year period, radiology report turnaround times for Medicare beneficiaries increased 113 percent with a total 87 percent increase occurring in 2022 and 2023, the last two years of a newly published retrospective study.

Catch up on the top radiology content of the past week.

In a new podcast episode, Jennifer Frontera, M.D., discussed new research demonstrating a significantly higher prevalence of mild cognitive impairment in patients with Long Covid.

Catch up on the top AI-related news and research in radiology over the past month.

Catch up on the top radiology content of the past week.

In an interview, W. Taylor Kimberly, M.D., discussed recent research showing that multidirectional diffusion-weighted imaging (DWI) on low-field MRI yielded a 95 percent positive predictive value (PPV) for detecting acute ischemic stroke.

Use of an MRI-based deep learning model also led to a greater than 33 percent increase in detecting brain metastases less than or equal to 3 mm, according to newly published research.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

Catch up on the top radiology content of the past week.

The MRI-based Early Recurrence Individualized Score (MERIS) demonstrated an 18 percent higher C-index than the Barcelona Clinic Liver Cancer (BCLC) staging system for predicting early recurrence of hepatocellular carcinoma (HCC) for patients who had resection of solitary HCC tumors.

Reportedly providing automation of 14 standard and advanced cardiac MRI views in less than 30 seconds, the SmartHeart also facilitates a 75 percent reduction in breath holds for basic MRI views.

Catch up on a variety of new FDA clearances and approvals in radiology from the past week.

Catch up on the top radiology content of the past week.

The MEDRAD MRXperion MR Injection System is cleared for use with low-field and high-field MRI platforms, including 7T MRI.

In comparison to LI-RADS version 2018 for MRI assessment, the use of perfluorobutane-enhanced ultrasound incorporating Kupffer-phase findings yielded comparable sensitivity and specificity for detecting hepatocellular carcinoma (HCC) nodules < 20 mm in high-risk patients, according to new research.









